Cargando…

Tumor Primary Location May Affect Metastasis Pattern for Patients with Stage IV NSCLC: A Population-Based Study

BACKGROUND: Most patients with nonsmall cell lung cancer (NSCLC) were initially diagnosed with distant metastasis. At present, there is no study to clarify the correlation between the primary location of the tumor and the metastasis pattern in advanced NSCLC. So we conducted this study to explored t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shan, Qinge, Li, Zhenxiang, Lin, Jiamao, Guo, Jun, Han, Xiao, Song, Xinyu, Wang, Haiyong, Wang, Zhehai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368215/ https://www.ncbi.nlm.nih.gov/pubmed/32695165 http://dx.doi.org/10.1155/2020/4784701

Ejemplares similares

PLNR≤20% may be a benefit from PORT for patients with IIIA-N2 NSCLC: a large population-based study
por: Shang, Xiaoling, et al.
Publicado: (2018)

A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC
por: Shang, Xiaoling, et al.
Publicado: (2019)

Surgical intervention may be a therapeutic option for NSCLC patients with AJCC stage IV: a large population-based study
por: Wang, Haiyong, et al.
Publicado: (2018)

Patients With BRAF-Mutant NSCLC May Not Benefit From Immune Checkpoint Inhibitors: A Population-Based Study
por: Zhang, Chenxing, et al.
Publicado: (2020)

Relationship between tumor size and metastatic site in patients with stage IV non-small cell lung cancer: A large SEER-based study
por: Shan, Qinge, et al.
Publicado: (2019)

Radiotherapy may improve survival of ES-SCLC with distant metastasis only for patients with one metastatic site: A population-based study
por: Shang, Xiaoling, et al.
Publicado: (2020)

Incorporating the Number of PLN into the AJCC Stage Could Better Predict the Survival for Patients with NSCLC: A Large Population-Based Study
por: Shang, Xiaoling, et al.
Publicado: (2020)

A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study
por: Shang, Xiaoling, et al.
Publicado: (2020)

A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study
por: Shan, Qinge, et al.
Publicado: (2021)

Duration of immunotherapy in patients with advanced lung adenocarcinoma with negative driver genes: case report and literature review
por: Shan, Qinge, et al.
Publicado: (2020)

Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types
por: Zhang, Chenyue, et al.
Publicado: (2020)

Molecular subtyping of small‐cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies
por: Wang, Haiyong, et al.
Publicado: (2022)

Estrogen Receptor β1 Expression Patterns Have Different Effects on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors’ Treatment Response in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma
por: Zhang, Lijuan, et al.
Publicado: (2021)

A 5-Genomic Mutation Signature Can Predict the Survival for Patients With NSCLC Receiving Atezolizumab
por: Lin, Jiamao, et al.
Publicado: (2021)

Circular RNA hsa_circ_0078602 may have potential as a prognostic biomarker for patients with hepatocellular carcinoma
por: Kou, Peisi, et al.
Publicado: (2019)

Different distant metastasis patterns based on tumor size could be found in extensive-stage small cell lung cancer patients: a large, population-based SEER study
por: Li, Jia, et al.
Publicado: (2019)

Clinicopathological Difference and Survival Impact of Patients with c-SCLC and SCLC
por: Zhang, Chenyue, et al.
Publicado: (2021)

Total lymphocyte count, neutrophil–lymphocyte ratio, and platelet–lymphocyte ratio as prognostic factors in advanced non–small cell lung cancer with chemoradiotherapy
por: Song, Xinyu, et al.
Publicado: (2018)

Impact of Radiotherapy Pattern on the Prognosis of Stage IV Lung Adenocarcinomas Harboring EGFR Mutations
por: Zhang, Yingyun, et al.
Publicado: (2021)

Screening differential circular RNA expression profiles reveal that hsa_circ_0128298 is a biomarker in the diagnosis and prognosis of hepatocellular carcinoma
por: Chen, Dawei, et al.
Publicado: (2018)

The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC
por: Verschueren, M. V., et al.
Publicado: (2021)

Surgery as a Potential Treatment Option for Patients With Stage III Small-Cell Lung Cancer: A Propensity Score Matching Analysis
por: Zhang, Chenyue, et al.
Publicado: (2019)

Genomic Variations and Immune-Related Features of TMB, PD-L1 Expression and CD8(+) T Cell Infiltration in Chinese Pulmonary Sarcomatoid Carcinoma
por: Zhang, Chenyue, et al.
Publicado: (2022)

Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer
por: Song, Xinyu, et al.
Publicado: (2018)

Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report
por: Guisier, F., et al.
Publicado: (2020)

Is primary tumor location an independent prognostic factor in stage IV colon cancer?
por: Yokoyama, Sachio, et al.
Publicado: (2019)

Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations
por: Ninomiya, Kiichiro, et al.
Publicado: (2020)

Excision of the primary in stage IV non-small cell lung cancer (NSCLC): A feasibility study
por: Dawson, Alan G, et al.
Publicado: (2015)

The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study
por: Chi, Huiying, et al.
Publicado: (2017)

EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers
por: Li, Zhenxiang, et al.
Publicado: (2022)

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)
por: Assi, Hazem I., et al.
Publicado: (2023)

Whole exome sequencing in Chinese mucinous pulmonary adenocarcinoma uncovers specific genetic variations different from lung adenocarcinoma
por: Zhang, Chenyue, et al.
Publicado: (2022)

Metastasis Patterns and Prognosis of Octogenarians with NSCLC: A Population-based Study
por: Gu, Yu, et al.
Publicado: (2020)

Tumor location may affect the clinicopathological features and prognosis of thymomas
por: Tian, Dong, et al.
Publicado: (2019)

Adaptive, Iterative, Long-Term Personalized Therapy Management in a Case of Stage IV Refractory NSCLC
por: Ranade, Anantbhushan, et al.
Publicado: (2019)

Clinical efficacy evaluation of tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations
por: Song, Xinyu, et al.
Publicado: (2017)

TP53 co-mutations in EGFR mutated patients in NSCLC stage IV: A strong predictive factor of ORR, PFS and OS in EGFR mt+ NSCLC
por: Roeper, Julia, et al.
Publicado: (2020)

Significance of lymph node metastasis in the survival of stage IV colorectal cancer by hematogenous metastasis
por: Han, Eon Chul, et al.
Publicado: (2018)

A Population-Based Analysis of Distant Metastasis in Stage IV Gastric Cancer
por: Zhang, Yiran, et al.
Publicado: (2020)

KRAS mutation and primary tumor location do not affect efficacy of bevacizumab-containing chemotherapy in stagae IV colorectal cancer patients
por: Sun, De-cong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v6n5jsiv5c55vn3k92fbh7v1sp